Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia

Molecular Psychiatry

Volumn 20, Issue 3, 2015, Pages 361-368

  Brennand, K ^a,b   Savas, J N ^c   Kim, Y ^b   Tran, N ^a,b   Simone, A ^b   Hashimoto Torii, K ^d,e   Beaumont, K G ^f,g   Kim, H J ^b   Topol, A ^a   Ladran, I ^a,b   Abdelrahim, M ^a   Matikainen Ankney, B ^a   Chao, S H ^h   Mrksich, M ^f,g   Rakic, P ^d   Fang, G ^a   Zhang, B ^a   Yates, J R ^c   Gage, F H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Northwestern University   (United States)

^h ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; STABLE ISOTOPE; NERVE CELL ADHESION MOLECULE; NEUROLEPTIC AGENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; ASSAY; CELL CULTURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MASS SPECTROMETRY; NEURAL STEM CELL; OXIDATIVE STRESS; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCHIZOPHRENIA; ADULT; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL MOTION; DRUG EFFECTS; FEMALE; FOREBRAIN; GENETICS; MALE; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; TRANSGENIC MOUSE; YOUNG ADULT;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; NEURAL CELL ADHESION MOLECULES; NEURAL STEM CELLS; OXIDATIVE STRESS; PHENOTYPE; PLURIPOTENT STEM CELLS; PROSENCEPHALON; PROTEOMICS; REACTIVE OXYGEN SPECIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84924721164     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.22     Document Type: Article

References (32)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669
2. White T, Anjum A, Schulz SC. The schizophrenia prodrome. Am J Psychiatry 2006; 163: 376-380
3. Wong AH, Van Tol HH. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev 2003; 27: 269-306
4. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013; 154: 518-529
5. Nicholas CR, Chen J, Tang Y, Southwell DG, Chalmers N, Vogt D, et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 2013; 12: 573-586
6. Mariani J, Simonini MV, Palejev D, Tomasini L, Coppola G, Szekely AM, et al. Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci USA 2012; 109: 12770-12775
7. Espuny-Camacho I, Michelsen KA, Gall D, Linaro D, Hasche A, Bonnefont J, et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 2013; 77: 440-456
8. Maroof AM, Keros S, Tyson JA, Ying SW, Ganat YM, Merkle FT, et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013; 12: 559-572
9. Hu BY, Du ZW, Zhang SC. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 2009; 4: 1614-1622
10. Wang S, Bates J, Li X, Schanz S, Chandler-Militello D, Levine C, et al. Human iPSCderived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 2013; 12: 252-264
11. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221-225
12. Wang IM, Zhang B, Yang X, Zhu J, Stepaniants S, Zhang C, et al. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 2012; 8: 594
13. Butko MT, Savas JN, Friedman B, Delahunty C, Ebner F, Yates JR3rd, et al. In vivo quantitative proteomics of somatosensory cortical synapses shows which protein levels are modulated by sensory deprivation. Proc Natl Acad Sci USA 2013; 110: E726-E735
14. Liao L, Park SK, Xu T, Vanderklish P, Yates JR 3rd. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci USA 2008; 105: 15281-15286
15. Delaloy C, Liu L, Lee JA, Su H, Shen F, Yang GY, et al. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 2010; 6: 323-335
16. Satoh T, Enokido Y, Aoshima H, Uchiyama Y, Hatanaka H. Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J Neurosci Res 1997; 50: 413-420
17. Paulsen BD, de Moraes Maciel R, Galina A, Souza da Silveira M, dos Santos Souza C, Drummond H, et al. Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant 2012; 21: 1547-1559
18. Sullivan PF. The genetics of schizophrenia. PLoS Med 2005; 2: e212
19. Kim JJ, Lee SJ, Toh KY, Lee CU, Lee C, Paik IH. Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia. Schizophr Res 2007; 52: 127-135
20. Pae CU, Kim TS, Kwon OJ, Artioli P, Serretti A, Lee CU, et al. Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia. Neurosci Res 2005; 53: 8-13
21. Robicsek O, Karry R, Petit I, Salman-Kesner N, Müller FJ, Klein E, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18: 1067-1076
22. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WEJr, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53: 425-436
23. Meechan DW, Tucker ES, Maynard TM, LaMantia AS. Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc Natl Acad Sci USA 2012; 109: 18601-18606
24. Meechan DW, Tucker ES, Maynard TM, LaMantia AS. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc Natl Acad Sci USA 2009; 106: 16434-16445
25. Kvajo M, McKellar H, Arguello PA, Drew LJ, Moore H, MacDermott AB, et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci USA 2008; 105: 7076-7081
26. Krivosheya D, Tapia L, Levinson JN, Huang K, Kang Y, Hines R, et al. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem 2008; 283: 32944-32956
27. Faulkner RL, Jang MH, Liu XB, Duan X, Sailor KA, Kim JY, et al. Development of hippocampal mossy fiber synaptic outputs by new neurons in the adult brain. Proc Natl Acad Sci USA 2008; 105: 14157-14162
28. Behrens MM, Sejnowski TJ. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 2009; 57: 193-200
29. Avery SV. Microbial cell individuality and the underlying sources of heterogeneity. Nat Rev Microbiol 2006; 4: 577-587
30. Bahar R, Hartmann CH, Rodriguez KA, Denny AD, Busuttil RA, Dollé ME, et al. Increased cell-To-cell variation in gene expression in ageing mouse heart. Nature 2006; 441: 1011-1014
31. Gry M, Rimini R, Strömberg S, Asplund A, Pontén F, Uhlén M, et al. Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 2009; 10: 365
32. An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, et al. Genetic correction of Huntington's Disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 2012; 11: 253-263